RecruitingNot ApplicableNCT06269809

Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

82 participants

Start Date

May 4, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the efficacy of temporary clipping of the uterine artery and utero-ovarian ligament during robotically assisted myomectomy (RAM) for uterine fibroids. While RAM is increasingly used for myomectomy, bleeding control remains challenging. Temporary clipping of arteries has shown promise in conventional laparoscopy but has not been studied in RAM. This randomized controlled trial will assess primary endpoints such as estimated blood loss, need for transfusion, and hemoglobin drop, alongside secondary outcomes like complication rates and operation time.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • Participants eligible for inclusion in this Trial must meet all of the following criteria:
  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% per year) when used consistently and correctly; such as implants, injectables, combined oral contraceptives, some IUDs, true sexual abstinence (i.e. refraining from heterosexual intercourse during the entire period of risk associated with the Trial treatment(s)) or commitment to a vasectomised partner.
  • Female
  • Age: 18-50 years
  • Myomas, eligible for myomectomy, with the exclusion of FIGO 7-8 myomas.

Exclusion Criteria7

  • Participants eligible for this Trial must not meet any of the following criteria:
  • Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
  • Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial
  • Participation in an interventional Trial with an investigational medicinal product (IMP) or device
  • Patient refusal to participate in the Trial
  • (Possible) malignancy
  • any contra indication for a laparoscopic or robotic surgery

Interventions

PROCEDURETemporary clipping of the uterine arteries and the utero-ovarian ligmants.

Temporary clipping of the uterine arteries and the utero-ovarian ligaments using laparoscopic clips/bulldog clamps, during robotically assisted myomectomy.

PROCEDURENo temporary clipping of the uterine arteries and the utero-ovarian ligmants.

Robotically assisted myomectomy, for which no temporary clipping of the uterine arteries and the utero-ovarian ligaments


Locations(4)

University Hospitals Leuven

Leuven, Belgium

Department of Gynecology and Obstetrics, Hopital Bichat

Paris, France

Service de gynécologie, Centre Hospitalier Universitaire de Rennes

Rennes, France

Amsterdam UMC, locatie VUmc

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06269809


Related Trials